Portunus trituberculatus isolate SZX2019 chromosome 20, ASM1759143v1, whole genome shotgun sequence.
Portunus trituberculatus (swimming crab)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Multicrustacea; Malacostraca; Eumalacostraca; Eucarida; Decapoda; Pleocyemata; Brachyura; Eubrachyura; Portunoidea; Portunidae; Portunus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM030090.1.\nAssembly name: ASM1759143v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Center for Ecological and\nEnvironmental Sciences on 2021/03/30. The original whole-genome\nshotgun project has the accession JAGGDN000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Center for Ecological and Environmental\n Sciences\nAssembly Method :: Wtdbg v. 2.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 54.74x\nSequencing Technology :: Oxford Nanopore; Illumina\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Portunus trituberculatus Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
WD repeat-containing protein 19-like, transcript variant X3
WD repeat-containing protein 19-like, transcript variant X2
WD repeat-containing protein 19-like, transcript variant X1
WD repeat-containing protein 19-like isoform X2
WD repeat-containing protein 19-like isoform X1
WD repeat-containing protein 19-like isoform X3
WD repeat-containing protein 19-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
WD repeat-containing protein 19-like isoform X4
adenylate cyclase type 9-like, transcript variant X2
adenylate cyclase type 9-like, transcript variant X3
adenylate cyclase type 9-like, transcript variant X4
adenylate cyclase type 9-like, transcript variant X1
adenylate cyclase type 9-like isoform X2
adenylate cyclase type 9-like isoform X3
adenylate cyclase type 9-like isoform X1
adenylate cyclase type 9-like isoform X4
adenylate cyclase type 9-like, transcript variant X5
adenylate cyclase type 9-like isoform X5
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3-like
HCLS1-associated protein X-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
HCLS1-associated protein X-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transcriptional protein SWT1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 3 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
transcriptional protein SWT1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 3 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
transcriptional protein SWT1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transcriptional protein SWT1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transcriptional protein SWT1-like isoform X2
transcriptional protein SWT1-like isoform X1
biogenesis of lysosome-related organelles complex 1 subunit 1-like
coatomer subunit alpha-like, transcript variant X1
coatomer subunit alpha-like, transcript variant X2
probable G-protein coupled receptor Mth-like 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: probable G-protein coupled receptor Mth-like 1
uncharacterized LOC123506620, transcript variant X2
uncharacterized LOC123506620, transcript variant X1
uncharacterized protein LOC123506620 isoform X2
uncharacterized protein LOC123506620 isoform X1
uncharacterized LOC123506667, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC123506667, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC123506667 isoform X2
uncharacterized protein LOC123506667 isoform X1
uncharacterized LOC123506667, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized protein LOC123506667 isoform X3
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon UAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 56% coverage of the annotated genomic feature by RNAseq alignments
protein FAM76A-like, transcript variant X1
protein FAM76A-like, transcript variant X2
protein lozenge-like, transcript variant X1
protein lozenge-like, transcript variant X2
runt-related transcription factor 1-like isoform X2
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
RNA-binding protein 33-like, transcript variant X3
meiotic recombination protein DMC1/LIM15 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
RNA-binding protein 33-like, transcript variant X1
RNA-binding protein 33-like, transcript variant X2
RNA-binding protein 33-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial-like, transcript variant X3
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial-like, transcript variant X4
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial-like, transcript variant X1
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial-like, transcript variant X2
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial-like
type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase-like
nuclear receptor coactivator 2-like, transcript variant X6
nuclear receptor coactivator 2-like, transcript variant X12
nuclear receptor coactivator 2-like, transcript variant X2
nuclear receptor coactivator 2-like, transcript variant X5
nuclear receptor coactivator 2-like, transcript variant X16
nuclear receptor coactivator 2-like, transcript variant X15
nuclear receptor coactivator 2-like, transcript variant X11
nuclear receptor coactivator 2-like, transcript variant X10
nuclear receptor coactivator 2-like, transcript variant X9
nuclear receptor coactivator 2-like, transcript variant X3
nuclear receptor coactivator 2-like, transcript variant X1
nuclear receptor coactivator 2-like, transcript variant X8
nuclear receptor coactivator 2-like, transcript variant X7
nuclear receptor coactivator 2-like, transcript variant X4
nuclear receptor coactivator 2-like, transcript variant X18
nuclear receptor coactivator 2-like, transcript variant X14
neurogenic protein mastermind-like isoform X6
AT-rich interactive domain-containing protein 1B-like isoform X12
AT-rich interactive domain-containing protein 1B-like isoform X2
trithorax group protein osa-like isoform X5
AT-rich interactive domain-containing protein 1B-like isoform X16
AT-rich interactive domain-containing protein 1B-like isoform X15
AT-rich interactive domain-containing protein 1B-like isoform X11
nuclear receptor coactivator 2-like isoform X10
nuclear receptor coactivator 2-like isoform X9
AT-rich interactive domain-containing protein 1B-like isoform X3
AT-rich interactive domain-containing protein 1B-like isoform X1
AT-rich interactive domain-containing protein 1B-like isoform X7
nuclear receptor coactivator 2-like isoform X18
AT-rich interactive domain-containing protein 1B-like isoform X4
AT-rich interactive domain-containing protein 1B-like isoform X8
nuclear receptor coactivator 2-like, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
nuclear receptor coactivator 2-like, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
period circadian protein-like isoform X17
nuclear receptor coactivator 2-like isoform X13
carnitine O-palmitoyltransferase 1, liver isoform-like
store-operated calcium entry-associated regulatory factor-like, transcript variant X1
store-operated calcium entry-associated regulatory factor-like, transcript variant X2
store-operated calcium entry-associated regulatory factor-like, transcript variant X3
store-operated calcium entry-associated regulatory factor-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: DNA polymerase iota-like
ribosomal RNA processing protein 36 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
protein white-like, transcript variant X1
protein white-like, transcript variant X2
gamma-soluble NSF attachment protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
gamma-soluble NSF attachment protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
gamma-soluble NSF attachment protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
gamma-soluble NSF attachment protein-like
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A-like
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A-like
uncharacterized LOC123506520, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123506520, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC123506520, transcript variant X1
uncharacterized protein LOC123506520 isoform X2
uncharacterized protein LOC123506520 isoform X1
uncharacterized LOC123506600, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123506600, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
katanin p80 WD40 repeat-containing subunit B1-like, transcript variant X13
katanin p80 WD40 repeat-containing subunit B1-like, transcript variant X9
katanin p80 WD40 repeat-containing subunit B1-like, transcript variant X12
katanin p80 WD40 repeat-containing subunit B1-like, transcript variant X6
katanin p80 WD40 repeat-containing subunit B1-like, transcript variant X11
katanin p80 WD40 repeat-containing subunit B1-like, transcript variant X10
katanin p80 WD40 repeat-containing subunit B1-like, transcript variant X5
katanin p80 WD40 repeat-containing subunit B1-like, transcript variant X4
katanin p80 WD40 repeat-containing subunit B1-like, transcript variant X8
katanin p80 WD40 repeat-containing subunit B1-like, transcript variant X7
katanin p80 WD40 repeat-containing subunit B1-like, transcript variant X3
katanin p80 WD40 repeat-containing subunit B1-like, transcript variant X1
katanin p80 WD40 repeat-containing subunit B1-like, transcript variant X2
katanin p80 WD40 repeat-containing subunit B1-like isoform X12
katanin p80 WD40 repeat-containing subunit B1-like isoform X8
katanin p80 WD40 repeat-containing subunit B1-like isoform X11
katanin p80 WD40 repeat-containing subunit B1-like isoform X5
katanin p80 WD40 repeat-containing subunit B1-like isoform X10
katanin p80 WD40 repeat-containing subunit B1-like isoform X9
katanin p80 WD40 repeat-containing subunit B1-like isoform X4
katanin p80 WD40 repeat-containing subunit B1-like isoform X3
katanin p80 WD40 repeat-containing subunit B1-like isoform X7
katanin p80 WD40 repeat-containing subunit B1-like isoform X6
katanin p80 WD40 repeat-containing subunit B1-like isoform X2
katanin p80 WD40 repeat-containing subunit B1-like isoform X1
probable aldehyde oxidase 2, transcript variant X1
probable aldehyde oxidase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123506555, transcript variant X4
uncharacterized LOC123506555, transcript variant X2
uncharacterized LOC123506555, transcript variant X1
uncharacterized LOC123506555, transcript variant X3
uncharacterized protein LOC123506555 isoform X4
uncharacterized protein LOC123506555 isoform X2
uncharacterized protein LOC123506555 isoform X3
uncharacterized protein LOC123506555 isoform X1
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
protein bric-a-brac 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein bric-a-brac 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
protein bric-a-brac 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
protein bric-a-brac 1-like, transcript variant X4
uncharacterized protein PB18E9.04c-like isoform X2
40S ribosomal protein S8, transcript variant X1
40S ribosomal protein S8, transcript variant X2
gastrula zinc finger protein XlCGF7.1-like, transcript variant X1
gastrula zinc finger protein XlCGF7.1-like, transcript variant X4
gastrula zinc finger protein XlCGF7.1-like, transcript variant X2
gastrula zinc finger protein XlCGF7.1-like, transcript variant X3
gastrula zinc finger protein XlCGF7.1-like isoform X1
gastrula zinc finger protein XlCGF7.1-like, transcript variant X5
microsomal glutathione S-transferase 3-like isoform X2
flocculation protein FLO11-like, transcript variant X3
flocculation protein FLO11-like, transcript variant X1
flocculation protein FLO11-like, transcript variant X2
flocculation protein FLO11-like, transcript variant X4
flocculation protein FLO11-like, transcript variant X6
flocculation protein FLO11-like, transcript variant X5
flocculation protein FLO11-like isoform X3
flocculation protein FLO11-like isoform X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized protein F09G8.5-like, transcript variant X1
uncharacterized protein F09G8.5-like, transcript variant X5
uncharacterized protein F09G8.5-like, transcript variant X4
uncharacterized protein F09G8.5-like, transcript variant X9
uncharacterized protein F09G8.5-like, transcript variant X2
uncharacterized protein F09G8.5-like, transcript variant X10
uncharacterized protein F09G8.5-like, transcript variant X6
uncharacterized protein F09G8.5-like, transcript variant X11
uncharacterized protein F09G8.5-like, transcript variant X3
uncharacterized protein F09G8.5-like, transcript variant X7
uncharacterized protein F09G8.5-like, transcript variant X8
uncharacterized protein F09G8.5-like, transcript variant X12
uncharacterized protein F09G8.5-like, transcript variant X13
uncharacterized protein LOC123506544 isoform X1
uncharacterized protein LOC123506544 isoform X3
uncharacterized protein LOC123506544 isoform X7
uncharacterized protein LOC123506544 isoform X5
uncharacterized protein LOC123506544 isoform X8
dynein axonemal assembly factor 11-like isoform X12
uncharacterized protein LOC123506544 isoform X4
uncharacterized protein LOC123506544 isoform X9
uncharacterized protein F09G8.5-like isoform X13
uncharacterized protein LOC123506544 isoform X2
uncharacterized protein LOC123506544 isoform X10
uncharacterized protein LOC123506544 isoform X6
uncharacterized protein F09G8.5-like isoform X11
tetraspanin-18-like, transcript variant X2
tetraspanin-18-like, transcript variant X1
adenine phosphoribosyltransferase 1-like, transcript variant X3
adenine phosphoribosyltransferase 1-like, transcript variant X4
adenine phosphoribosyltransferase 1-like, transcript variant X1
adenine phosphoribosyltransferase 1-like, transcript variant X2
adenine phosphoribosyltransferase 1-like
hemicentin-2-like, transcript variant X1
hemicentin-2-like, transcript variant X5
hemicentin-2-like, transcript variant X3
hemicentin-2-like, transcript variant X2
hemicentin-2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ran GTPase-activating protein 1-like, transcript variant X3
ran GTPase-activating protein 1-like isoform X3
uncharacterized LOC123506551, transcript variant X1
uncharacterized LOC123506551, transcript variant X2
uncharacterized protein LOC123506551 isoform X2
uncharacterized protein LOC123506551 isoform X1
ran GTPase-activating protein 1-like, transcript variant X2
ran GTPase-activating protein 1-like isoform X2
ran GTPase-activating protein 1-like, transcript variant X1
ran GTPase-activating protein 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
putative uncharacterized protein DDB_G0271606
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
uncharacterized LOC123506687, transcript variant X3
uncharacterized LOC123506687, transcript variant X4
uncharacterized LOC123506687, transcript variant X1
uncharacterized LOC123506687, transcript variant X2
uncharacterized LOC123506687, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC123506687 isoform X2
uncharacterized protein LOC123506687 isoform X1
carbonic anhydrase-related protein 10-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
85/88 kDa calcium-independent phospholipase A2-like, transcript variant X5
85/88 kDa calcium-independent phospholipase A2-like, transcript variant X2
85/88 kDa calcium-independent phospholipase A2-like, transcript variant X4
85/88 kDa calcium-independent phospholipase A2-like, transcript variant X3
85/88 kDa calcium-independent phospholipase A2-like, transcript variant X1
85/88 kDa calcium-independent phospholipase A2-like isoform X2
85/88 kDa calcium-independent phospholipase A2-like isoform X4
85/88 kDa calcium-independent phospholipase A2-like isoform X1
85/88 kDa calcium-independent phospholipase A2-like isoform X3
gem-associated protein 2-like, transcript variant X2
gem-associated protein 2-like, transcript variant X3
gem-associated protein 2-like isoform X3
gem-associated protein 2-like isoform X2
gem-associated protein 2-like, transcript variant X1
gem-associated protein 2-like isoform X1
protein scarlet-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein scarlet-like, transcript variant X5
protein scarlet-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein scarlet-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein scarlet-like, transcript variant X3
protein scarlet-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123506742, transcript variant X10
uncharacterized LOC123506742, transcript variant X2
uncharacterized LOC123506742, transcript variant X9
uncharacterized LOC123506742, transcript variant X1
uncharacterized LOC123506742, transcript variant X3
uncharacterized LOC123506742, transcript variant X8
uncharacterized LOC123506742, transcript variant X4
uncharacterized LOC123506742, transcript variant X7
uncharacterized LOC123506742, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123506742, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123506743, transcript variant X6
uncharacterized LOC123506743, transcript variant X5
uncharacterized LOC123506743, transcript variant X1
uncharacterized LOC123506743, transcript variant X4
uncharacterized LOC123506743, transcript variant X7
uncharacterized LOC123506743, transcript variant X3
uncharacterized LOC123506743, transcript variant X2
uncharacterized protein LOC123506743 isoform X4
uncharacterized protein LOC123506743 isoform X2
uncharacterized protein LOC123506743 isoform X5
uncharacterized protein LOC123506743 isoform X6
uncharacterized protein LOC123506743 isoform X3
uncharacterized protein LOC123506743 isoform X1
uncharacterized LOC123506745, transcript variant X3
uncharacterized LOC123506745, transcript variant X1
uncharacterized LOC123506745, transcript variant X4
uncharacterized LOC123506745, transcript variant X2
uncharacterized protein LOC123506745 isoform X1
uncharacterized protein LOC123506745 isoform X2
neo-calmodulin-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 107 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
neo-calmodulin-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 107 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
neo-calmodulin-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 107 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neo-calmodulin-like, transcript variant X2
neo-calmodulin-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 107 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc finger CCHC-type and RNA-binding motif-containing protein 1-like, transcript variant X2
PAT complex subunit CCDC47-like, transcript variant X2
PAT complex subunit CCDC47-like, transcript variant X3
PAT complex subunit CCDC47-like, transcript variant X4
PAT complex subunit CCDC47-like, transcript variant X1
PAT complex subunit CCDC47-like isoform X3
PAT complex subunit CCDC47-like isoform X2
PAT complex subunit CCDC47-like isoform X1
PAT complex subunit CCDC47-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 long SRA reads, 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
PAT complex subunit CCDC47-like isoform X4
zinc finger CCHC-type and RNA-binding motif-containing protein 1-like, transcript variant X1
zinc finger CCHC-type and RNA-binding motif-containing protein 1-like
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X2
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X3
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X1
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like isoform X2
3-oxoacyl-[acyl-carrier-protein] reductase FabG-like isoform X3
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
LOW QUALITY PROTEIN: uncharacterized protein LOC123506747
regulator of G-protein signaling 10-like, transcript variant X3
regulator of G-protein signaling 10-like, transcript variant X6
regulator of G-protein signaling 10-like, transcript variant X1
regulator of G-protein signaling 10-like, transcript variant X2
regulator of G-protein signaling 10-like, transcript variant X4
regulator of G-protein signaling 10-like, transcript variant X5
regulator of G-protein signaling 10-like isoform X2
regulator of G-protein signaling 10-like isoform X1
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123506619, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123506619, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 81% coverage of the annotated genomic feature by RNAseq alignments
carbohydrate sulfotransferase 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
carbohydrate sulfotransferase 5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
carbohydrate sulfotransferase 5-like isoform X1
carbohydrate sulfotransferase 4-like isoform X2
histone-lysine N-methyltransferase PRDM16-like
LOW QUALITY PROTEIN: histone-lysine N-methyltransferase PRDM16-like
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
histone-lysine N-methyltransferase MECOM-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized LOC123506578, transcript variant X1
uncharacterized LOC123506578, transcript variant X2
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
proline-rich protein 36-like, transcript variant X3
proline-rich protein 36-like, transcript variant X1
proline-rich protein 36-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tRNA (adenine(37)-N6)-methyltransferase-like
LOW QUALITY PROTEIN: tRNA (adenine(37)-N6)-methyltransferase-like
TGF-beta receptor type-1-like, transcript variant X1
TGF-beta receptor type-1-like, transcript variant X2
TGF-beta receptor type-1-like, transcript variant X3
TGF-beta receptor type-1-like, transcript variant X5
TGF-beta receptor type-1-like, transcript variant X4
TGF-beta receptor type-1-like, transcript variant X6
TGF-beta receptor type-1-like, transcript variant X7
TGF-beta receptor type-1-like, transcript variant X9
TGF-beta receptor type-1-like, transcript variant X8
TGF-beta receptor type-1-like, transcript variant X10
TGF-beta receptor type-1-like, transcript variant X11
TGF-beta receptor type-1-like, transcript variant X13
TGF-beta receptor type-1-like, transcript variant X12
TGF-beta receptor type-1-like, transcript variant X14
TGF-beta receptor type-1-like isoform X1
TGF-beta receptor type-1-like isoform X2
TGF-beta receptor type-1-like isoform X3
TGF-beta receptor type-1-like isoform X5
TGF-beta receptor type-1-like isoform X4
TGF-beta receptor type-1-like isoform X6
TGF-beta receptor type-1-like isoform X7
TGF-beta receptor type-1-like isoform X9
TGF-beta receptor type-1-like isoform X8
TGF-beta receptor type-1-like isoform X10
activin receptor type-1C-like isoform X11
activin receptor type-1C-like isoform X13
TGF-beta receptor type-1-like isoform X12
TGF-beta receptor type-1-like isoform X14
probable cleavage and polyadenylation specificity factor subunit 2
growth arrest and DNA damage-inducible proteins-interacting protein 1-like
immediate early response gene 5 protein-like
(E3-independent) E2 ubiquitin-conjugating enzyme-like, transcript variant X1
(E3-independent) E2 ubiquitin-conjugating enzyme-like, transcript variant X3
(E3-independent) E2 ubiquitin-conjugating enzyme-like, transcript variant X4
(E3-independent) E2 ubiquitin-conjugating enzyme-like, transcript variant X5
(E3-independent) E2 ubiquitin-conjugating enzyme-like, transcript variant X2
(E3-independent) E2 ubiquitin-conjugating enzyme-like isoform X1
(E3-independent) E2 ubiquitin-conjugating enzyme-like isoform X3
(E3-independent) E2 ubiquitin-conjugating enzyme-like isoform X4
(E3-independent) E2 ubiquitin-conjugating enzyme-like isoform X5
(E3-independent) E2 ubiquitin-conjugating enzyme-like isoform X2
serine/threonine-protein kinase ULK3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transmembrane protein 53-B-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane protein 53-B-like, transcript variant X4
transmembrane protein 53-B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transmembrane protein 53-B-like, transcript variant X5
transmembrane protein 53-B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transmembrane protein 53-B-like, transcript variant X3
transmembrane protein 53-B-like isoform X1
transmembrane protein 53-B-like isoform X4
transmembrane protein 53-B-like isoform X2
transmembrane protein 53-B-like isoform X6
transmembrane protein 53-B-like isoform X3
transmembrane protein 53-B-like isoform X5
arginine-glutamic acid dipeptide repeats protein-like
unconventional myosin-XV-like, transcript variant X2
unconventional myosin-XV-like, transcript variant X1
unconventional myosin-XV-like, transcript variant X3
unconventional myosin-XV-like isoform X2
unconventional myosin-XV-like isoform X3
unconventional myosin-XV-like isoform X1
cyclic nucleotide-gated cation channel beta-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cyclic nucleotide-gated cation channel beta-1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cyclic nucleotide-gated cation channel beta-1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cyclic nucleotide-gated cation channel beta-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cyclic nucleotide-gated cation channel beta-1-like isoform X1
cyclic nucleotide-gated cation channel beta-1-like isoform X2
cyclic nucleotide-gated cation channel beta-1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70% coverage of the annotated genomic feature by RNAseq alignments
similar to RNA sequence (same species):INSD:GFFJ01064056.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 57 bases not found in genome assembly
transmembrane protein 203-like, transcript variant X2
transmembrane protein 203-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transcription elongation factor A N-terminal and central domain-containing protein 2-like
heparan-sulfate 6-O-sulfotransferase 1-B-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: heparan-sulfate 6-O-sulfotransferase 1-B-like
histone acetyltransferase type B catalytic subunit-like, transcript variant X1
histone acetyltransferase type B catalytic subunit-like, transcript variant X2
histone acetyltransferase type B catalytic subunit-like, transcript variant X3
histone acetyltransferase type B catalytic subunit-like isoform X2
histone acetyltransferase type B catalytic subunit-like isoform X1
histone acetyltransferase type B catalytic subunit-like isoform X3
uncharacterized LOC123506791, transcript variant X3
uncharacterized LOC123506791, transcript variant X1
uncharacterized LOC123506791, transcript variant X2
uncharacterized protein LOC123506791 isoform X1
uncharacterized protein LOC123506791 isoform X3
uncharacterized protein LOC123506791 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 long SRA reads, 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 59% coverage of the annotated genomic feature by RNAseq alignments
trifunctional enzyme subunit beta, mitochondrial-like
LOW QUALITY PROTEIN: uncharacterized protein LOC123506793
survival motor neuron protein-like, transcript variant X8
survival motor neuron protein-like, transcript variant X5
survival motor neuron protein-like, transcript variant X9
survival motor neuron protein-like, transcript variant X6
survival motor neuron protein-like, transcript variant X4
survival motor neuron protein-like, transcript variant X1
survival motor neuron protein-like, transcript variant X3
survival motor neuron protein-like, transcript variant X2
survival motor neuron protein-like isoform X6
survival motor neuron protein-like isoform X3
survival motor neuron protein-like isoform X7
survival motor neuron protein-like isoform X4
survival motor neuron protein-like isoform X2
survival motor neuron protein-like isoform X1
survival motor neuron protein-like, transcript variant X7
survival motor neuron protein-like isoform X5
uncharacterized LOC123506798, transcript variant X1
uncharacterized LOC123506798, transcript variant X2
uncharacterized LOC123506798, transcript variant X6
uncharacterized LOC123506798, transcript variant X3
uncharacterized LOC123506798, transcript variant X10
uncharacterized LOC123506798, transcript variant X5
uncharacterized LOC123506798, transcript variant X4
uncharacterized LOC123506798, transcript variant X8
uncharacterized LOC123506798, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC123506798, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
rho guanine nucleotide exchange factor 11-like
similar to RNA sequence (same species):INSD:GFFJ01013223.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 146 bases not found in genome assembly
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 146 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
uncharacterized LOC123506801, transcript variant X5
uncharacterized protein LOC123506801 isoform X5
uncharacterized LOC123506801, transcript variant X4
uncharacterized LOC123506801, transcript variant X1
uncharacterized LOC123506801, transcript variant X3
uncharacterized protein LOC123506801 isoform X1
uncharacterized protein LOC123506801 isoform X3
uncharacterized protein LOC123506801 isoform X4
uncharacterized LOC123506801, transcript variant X2
uncharacterized protein LOC123506801 isoform X2
cytochrome P450 2C31-like, transcript variant X1
similar to RNA sequence (same species):INSD:GFFJ01040098.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 287 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cytochrome P450 2C31-like, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 287 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 178 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
cuticle protein CP1246-like, transcript variant X2
cuticle protein CP1246-like, transcript variant X1
uncharacterized LOC123506672, transcript variant X2
uncharacterized protein LOC123506672 isoform X2
uncharacterized LOC123506672, transcript variant X1
uncharacterized protein LOC123506672 isoform X1
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123506609, transcript variant X1
uncharacterized LOC123506609, transcript variant X2
LOW QUALITY PROTEIN: uncharacterized protein LOC123506601
uncharacterized LOC123506603, transcript variant X3
uncharacterized LOC123506603, transcript variant X2
uncharacterized LOC123506603, transcript variant X4
uncharacterized LOC123506603, transcript variant X1
uncharacterized protein LOC123506603 isoform X2
uncharacterized protein LOC123506603 isoform X3
uncharacterized protein LOC123506603 isoform X1
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon CAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
zwei Ig domain protein zig-8-like, transcript variant X2
zwei Ig domain protein zig-8-like, transcript variant X1
zwei Ig domain protein zig-8-like, transcript variant X3
zwei Ig domain protein zig-8-like isoform X1
zwei Ig domain protein zig-8-like isoform X2
zwei Ig domain protein zig-8-like isoform X3
hepatocyte growth factor-regulated tyrosine kinase substrate-like
E3 SUMO-protein ligase ZBED1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments
E3 SUMO-protein ligase ZBED1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 SUMO-protein ligase ZBED1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 SUMO-protein ligase ZBED1-like, transcript variant X4
E3 SUMO-protein ligase ZBED1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
E3 SUMO-protein ligase ZBED1-like isoform X1
E3 SUMO-protein ligase ZBED1-like isoform X2
transfer RNA valine (anticodon GAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123506776, transcript variant X3
uncharacterized LOC123506776, transcript variant X4
uncharacterized LOC123506776, transcript variant X2
uncharacterized LOC123506776, transcript variant X5
uncharacterized LOC123506776, transcript variant X6
uncharacterized LOC123506776, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X2
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X1
gamma-aminobutyric acid receptor subunit beta-like isoform X1
gamma-aminobutyric acid receptor subunit beta-like isoform X2
uncharacterized LOC123506771, transcript variant X5
uncharacterized LOC123506771, transcript variant X3
uncharacterized LOC123506771, transcript variant X2
uncharacterized LOC123506771, transcript variant X4
uncharacterized LOC123506771, transcript variant X6
uncharacterized LOC123506771, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
dnaJ homolog subfamily C member 24-like, transcript variant X1
dnaJ homolog subfamily C member 24-like, transcript variant X3
dnaJ homolog subfamily C member 24-like, transcript variant X2
dnaJ homolog subfamily C member 24-like isoform X1
dnaJ homolog subfamily C member 24-like isoform X3
dnaJ homolog subfamily C member 24-like isoform X2
histone-lysine N-methyltransferase SMYD3-like, transcript variant X1
histone-lysine N-methyltransferase SMYD3-like isoform X1
histone-lysine N-methyltransferase SMYD3-like, transcript variant X2
histone-lysine N-methyltransferase SMYD3-like isoform X2
LOW QUALITY PROTEIN: homeobox protein ARX-like
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
glutenin, low molecular weight subunit-like
dorsal root ganglia homeobox protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dorsal root ganglia homeobox protein-like, transcript variant X1
dorsal root ganglia homeobox protein-like isoform X2
dorsal root ganglia homeobox protein-like isoform X1
uncharacterized LOC123506700, transcript variant X2
uncharacterized LOC123506700, transcript variant X1
uncharacterized LOC123506699, transcript variant X1
uncharacterized protein LOC123506699 isoform X1
uncharacterized LOC123506699, transcript variant X3
uncharacterized LOC123506699, transcript variant X2
uncharacterized protein LOC123506699 isoform X2
uncharacterized protein LOC123506699 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 98% coverage of the annotated genomic feature by RNAseq alignments
leukocyte elastase inhibitor-like, transcript variant X2
leukocyte elastase inhibitor-like, transcript variant X1
leukocyte elastase inhibitor-like isoform X1
leukocyte elastase inhibitor-like isoform X2
LOW QUALITY PROTEIN: leukocyte elastase inhibitor-like
putative uncharacterized protein DDB_G0291608
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
LOW QUALITY PROTEIN: putative uncharacterized protein DDB_G0291608
Golgi phosphoprotein 3 homolog sauron-like
sideroflexin-1-like, transcript variant X3
sideroflexin-1-like, transcript variant X4
sideroflexin-1-like, transcript variant X1
sideroflexin-1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
sideroflexin-1-like, transcript variant X2
myb/SANT-like DNA-binding domain-containing protein 3
translationally-controlled tumor protein homolog
LOW QUALITY PROTEIN: translationally-controlled tumor protein homolog
potassium voltage-gated channel protein Shaw-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
potassium voltage-gated channel protein Shaw-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium voltage-gated channel protein Shaw-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
potassium voltage-gated channel protein Shaw-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
potassium voltage-gated channel protein Shaw-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
potassium voltage-gated channel protein Shaw-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel protein Shaw-like isoform X2
potassium voltage-gated channel protein Shaw-like isoform X1
splicing factor, proline- and glutamine-rich-like, transcript variant X1
splicing factor, proline- and glutamine-rich-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
splicing factor, proline- and glutamine-rich-like, transcript variant X3
splicing factor, proline- and glutamine-rich-like, transcript variant X4
splicing factor, proline- and glutamine-rich-like isoform X1
splicing factor, proline- and glutamine-rich-like isoform X2
COP9 signalosome complex subunit 5-like, transcript variant X2
COP9 signalosome complex subunit 5-like, transcript variant X1
COP9 signalosome complex subunit 5-like, transcript variant X3
COP9 signalosome complex subunit 5-like, transcript variant X4
COP9 signalosome complex subunit 5-like, transcript variant X6
COP9 signalosome complex subunit 5-like, transcript variant X5
acyl-coenzyme A amino acid N-acyltransferase 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins
malignant T-cell-amplified sequence 1-like
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like
PR domain zinc finger protein 15-like, transcript variant X1
PR domain zinc finger protein 15-like, transcript variant X2
PR domain zinc finger protein 15-like isoform X1
PR domain zinc finger protein 15-like isoform X2
uncharacterized LOC123506444, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123506444, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123506444, transcript variant X1
uncharacterized LOC123506444, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123506444, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC123506444 isoform X3
uncharacterized protein LOC123506444 isoform X1
uncharacterized protein LOC123506444 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123506447, transcript variant X2
uncharacterized protein LOC123506447 isoform X2
uncharacterized LOC123506447, transcript variant X1
uncharacterized protein LOC123506447 isoform X1
uncharacterized LOC123506447, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC123506447 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 93% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and IBR domain-containing protein 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ankyrin repeat and IBR domain-containing protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ankyrin repeat and IBR domain-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ankyrin repeat and IBR domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ankyrin repeat and IBR domain-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ankyrin repeat and IBR domain-containing protein 1-like isoform X2
ankyrin repeat and IBR domain-containing protein 1-like isoform X3
ankyrin repeat and IBR domain-containing protein 1-like isoform X1
uncharacterized LOC123506451, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC123506451, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC123506451, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC123506450, transcript variant X2
uncharacterized LOC123506450, transcript variant X1
uncharacterized protein LOC123506450 isoform X2
uncharacterized protein LOC123506450 isoform X1
BTB/POZ domain-containing protein 9-like, transcript variant X4
BTB/POZ domain-containing protein 9-like, transcript variant X1
BTB/POZ domain-containing protein 9-like, transcript variant X3
BTB/POZ domain-containing protein 9-like, transcript variant X2
BTB/POZ domain-containing protein 9-like, transcript variant X5
BTB/POZ domain-containing protein 9-like, transcript variant X7
BTB/POZ domain-containing protein 9-like, transcript variant X6
BTB/POZ domain-containing protein 9-like, transcript variant X8
BTB/POZ domain-containing protein 9-like isoform X4
BTB/POZ domain-containing protein 9-like isoform X1
BTB/POZ domain-containing protein 9-like isoform X3
BTB/POZ domain-containing protein 9-like isoform X2
BTB/POZ domain-containing protein 9-like isoform X5
BTB/POZ domain-containing protein 9-like isoform X7
BTB/POZ domain-containing protein 9-like isoform X6
BTB/POZ domain-containing protein 9-like isoform X8
BTB/POZ domain-containing protein 9-like, transcript variant X9
BTB/POZ domain-containing protein 9-like isoform X9
homeobox protein engrailed-1-B-like, transcript variant X1
homeobox protein engrailed-1-B-like, transcript variant X2
homeobox protein engrailed-1-B-like isoform X1
homeobox protein engrailed-1-B-like isoform X2
LOW QUALITY PROTEIN: homeobox protein engrailed-1-B-like
TATA-binding protein-associated factor 2N-like
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
lys-63-specific deubiquitinase BRCC36-like, transcript variant X6
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A-like isoform X2
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A-like isoform X1
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A-like isoform X3
lys-63-specific deubiquitinase BRCC36-like, transcript variant X2
lys-63-specific deubiquitinase BRCC36-like isoform X2
lys-63-specific deubiquitinase BRCC36-like, transcript variant X3
lys-63-specific deubiquitinase BRCC36-like, transcript variant X5
lys-63-specific deubiquitinase BRCC36-like, transcript variant X4
lys-63-specific deubiquitinase BRCC36-like, transcript variant X1
lys-63-specific deubiquitinase BRCC36-like isoform X1
lys-63-specific deubiquitinase BRCC36-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger BED domain-containing protein 5-like
uncharacterized LOC123506476, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123506476, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC123506476, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123506476, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123506476, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123506476, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X4
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X1
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X2
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like isoform X1
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like isoform X3
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123506479, transcript variant X1
uncharacterized LOC123506479, transcript variant X3
uncharacterized LOC123506479, transcript variant X2
uncharacterized LOC123506479, transcript variant X4
uncharacterized protein LOC123506479 isoform X2
uncharacterized protein LOC123506479 isoform X4
uncharacterized protein LOC123506479 isoform X1
uncharacterized protein LOC123506479 isoform X3
uncharacterized LOC123506480, transcript variant X1
uncharacterized LOC123506480, transcript variant X2
uncharacterized protein LOC123506480 isoform X1
uncharacterized protein LOC123506480 isoform X2
retinol-binding protein pinta-like, transcript variant X6
retinol-binding protein pinta-like, transcript variant X2
retinol-binding protein pinta-like, transcript variant X4
retinol-binding protein pinta-like, transcript variant X3
retinol-binding protein pinta-like, transcript variant X5
retinol-binding protein pinta-like, transcript variant X1
alpha-tocopherol transfer protein-like isoform X2
alpha-tocopherol transfer protein-like isoform X4
alpha-tocopherol transfer protein-like isoform X3
alpha-tocopherol transfer protein-like isoform X5
retinol-binding protein pinta-like isoform X1
heat-stable enterotoxin receptor-like, transcript variant X1
heat-stable enterotoxin receptor-like, transcript variant X2
heat-stable enterotoxin receptor-like isoform X1
heat-stable enterotoxin receptor-like isoform X2
synaptic vesicular amine transporter-like, transcript variant X3
synaptic vesicular amine transporter-like, transcript variant X2
synaptic vesicular amine transporter-like, transcript variant X1
synaptic vesicular amine transporter-like
trans-1,2-dihydrobenzene-1,2-diol dehydrogenase-like, transcript variant X2
trans-1,2-dihydrobenzene-1,2-diol dehydrogenase-like isoform X2
trans-1,2-dihydrobenzene-1,2-diol dehydrogenase-like, transcript variant X1
trans-1,2-dihydrobenzene-1,2-diol dehydrogenase-like isoform X1
trans-1,2-dihydrobenzene-1,2-diol dehydrogenase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123506427, transcript variant X4
uncharacterized LOC123506427, transcript variant X3
uncharacterized LOC123506427, transcript variant X1
uncharacterized LOC123506427, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 68% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid receptor subunit gamma-4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamate-gated chloride channel alpha-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
iron-sulfur cluster co-chaperone protein HscB-like
eye-specific diacylglycerol kinase-like, transcript variant X10
eye-specific diacylglycerol kinase-like, transcript variant X11
eye-specific diacylglycerol kinase-like, transcript variant X12
eye-specific diacylglycerol kinase-like isoform X8
eye-specific diacylglycerol kinase-like, transcript variant X8
eye-specific diacylglycerol kinase-like isoform X6
eye-specific diacylglycerol kinase-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
eye-specific diacylglycerol kinase-like, transcript variant X3
eye-specific diacylglycerol kinase-like, transcript variant X2
eye-specific diacylglycerol kinase-like, transcript variant X1
eye-specific diacylglycerol kinase-like, transcript variant X5
eye-specific diacylglycerol kinase-like, transcript variant X6
eye-specific diacylglycerol kinase-like, transcript variant X7
eye-specific diacylglycerol kinase-like, transcript variant X4
diacylglycerol kinase zeta-like isoform X1
diacylglycerol kinase zeta-like isoform X3
diacylglycerol kinase zeta-like isoform X4
diacylglycerol kinase zeta-like isoform X5
diacylglycerol kinase zeta-like isoform X2
eye-specific diacylglycerol kinase-like isoform X7
uncharacterized LOC123506761, transcript variant X2
uncharacterized LOC123506761, transcript variant X1
uncharacterized LOC123506762, transcript variant X1
uncharacterized LOC123506762, transcript variant X2
uncharacterized LOC123506528, transcript variant X2
uncharacterized LOC123506528, transcript variant X1
uncharacterized protein LOC123506528 isoform X1
uncharacterized protein LOC123506528 isoform X2
peptidyl-prolyl cis-trans isomerase G-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
multiple epidermal growth factor-like domains protein 6, transcript variant X1
multiple epidermal growth factor-like domains protein 6, transcript variant X2
multiple epidermal growth factor-like domains protein 6 isoform X1
multiple epidermal growth factor-like domains protein 6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phytanoyl-CoA dioxygenase domain-containing protein 1-like, transcript variant X1
phytanoyl-CoA dioxygenase domain-containing protein 1-like, transcript variant X2
phytanoyl-CoA dioxygenase domain-containing protein 1-like
bestrophin-1-like, transcript variant X2
bestrophin-1-like, transcript variant X3
bestrophin-1-like, transcript variant X8
bestrophin-1-like, transcript variant X9
bestrophin-1-like, transcript variant X6
bestrophin-1-like, transcript variant X11
bestrophin-1-like, transcript variant X7
bestrophin-1-like, transcript variant X10
bestrophin-1-like, transcript variant X4
bestrophin-1-like, transcript variant X1
bestrophin-1-like, transcript variant X12
bestrophin-1-like, transcript variant X5
bestrophin-1-like, transcript variant X13
uncharacterized LOC123506693, transcript variant X1
uncharacterized LOC123506693, transcript variant X2
uncharacterized LOC123506692, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC123506692, transcript variant X1
octopamine receptor beta-2R-like, transcript variant X1
octopamine receptor beta-2R-like, transcript variant X2
uncharacterized LOC123506763, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123506763, transcript variant X3
uncharacterized LOC123506763, transcript variant X4
uncharacterized LOC123506763, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
disco-interacting protein 2-like, transcript variant X7
disco-interacting protein 2-like, transcript variant X10
disco-interacting protein 2-like, transcript variant X11
disco-interacting protein 2-like, transcript variant X12
disco-interacting protein 2-like isoform X7
disco-interacting protein 2-like isoform X10
disco-interacting protein 2-like isoform X11
disco-interacting protein 2-like isoform X12
disco-interacting protein 2-like, transcript variant X1
disco-interacting protein 2-like, transcript variant X2
disco-interacting protein 2-like, transcript variant X3
disco-interacting protein 2-like, transcript variant X4
disco-interacting protein 2-like, transcript variant X5
disco-interacting protein 2 homolog C-like isoform X1
disco-interacting protein 2 homolog C-like isoform X2
disco-interacting protein 2 homolog C-like isoform X3
disco-interacting protein 2 homolog C-like isoform X4
disco-interacting protein 2 homolog A-like isoform X5
disco-interacting protein 2-like, transcript variant X6
disco-interacting protein 2-like, transcript variant X13
disco-interacting protein 2-like, transcript variant X8
disco-interacting protein 2-like, transcript variant X9
disco-interacting protein 2 homolog C-like isoform X6
disco-interacting protein 2 homolog C-like isoform X13
disco-interacting protein 2 homolog C-like isoform X8
disco-interacting protein 2-like isoform X9
transfer RNA cysteine (anticodon ACA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
39S ribosomal protein L32, mitochondrial-like
sortilin-related receptor-like, transcript variant X3
sortilin-related receptor-like, transcript variant X2
sortilin-related receptor-like, transcript variant X1
low-density lipoprotein receptor-related protein 2-like isoform X3
sortilin-related receptor-like isoform X2
sortilin-related receptor-like isoform X1
cell wall protein RBR3-like, transcript variant X3
cell wall protein RBR3-like, transcript variant X1
cell wall protein RBR3-like, transcript variant X2
uncharacterized LOC123506594, transcript variant X2
uncharacterized LOC123506594, transcript variant X1
uncharacterized protein LOC123506594 isoform X1
uncharacterized protein LOC123506594 isoform X2
uncharacterized LOC123506592, transcript variant X2
uncharacterized LOC123506592, transcript variant X4
uncharacterized LOC123506592, transcript variant X3
uncharacterized LOC123506592, transcript variant X1
uncharacterized protein LOC123506592 isoform X1
uncharacterized protein LOC123506592 isoform X2
proline-rich protein 36-like, transcript variant X4
histone-lysine N-methyltransferase 2D-like isoform X4
alanine aminotransferase 1-like, transcript variant X1
alanine aminotransferase 1-like isoform X1
alanine aminotransferase 1-like, transcript variant X2
alanine aminotransferase 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
uncharacterized LOC123506719, transcript variant X2
uncharacterized LOC123506719, transcript variant X1
uncharacterized LOC123506575, transcript variant X3
uncharacterized LOC123506575, transcript variant X1
uncharacterized protein LOC123506575 isoform X1
uncharacterized protein LOC123506575 isoform X3
uncharacterized LOC123506575, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized protein LOC123506575 isoform X2
uncharacterized LOC123506575, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein LOC123506575 isoform X4
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.